The Effect of Emotional Freedom Techniques Application on Nurses
Launched by GÜRKAN · Feb 14, 2024
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying how a technique called Emotional Freedom Techniques (EFT) can help reduce stress and alarm fatigue among nurses working in surgical intensive care units (ICUs). Nurses in these settings often deal with high levels of stress due to the demands of their job, including the constant noise from medical devices that can lead to alarm fatigue—where they become less responsive to important alerts. This study aims to see if using EFT can improve their mental health and overall job performance, ultimately leading to better care for patients.
To participate in the trial, nurses must be at least 18 years old and currently working in a surgical ICU. They also need to be willing to volunteer for the study. If eligible, participants can expect to engage in sessions that teach them how to use EFT to manage their stress levels. The trial is currently looking for volunteers, and it's a great opportunity for nurses to learn skills that may not only help them at work but also improve their well-being.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being 18 years of age or older
- • Working as a nurse in one of the surgical intensive care units
- • Volunteering to participate in the study
- Exclusion Criteria:
- • Working in a unit other than surgical intensive care units
- • Not volunteering to participate in the research
About Gürkan
Gürkan is a leading clinical trial sponsor dedicated to advancing medical research and innovation through rigorous and ethical clinical studies. With a commitment to improving patient outcomes, Gürkan collaborates with healthcare professionals, institutions, and regulatory bodies to design and execute clinical trials that meet the highest standards of scientific integrity. The organization focuses on a diverse range of therapeutic areas, leveraging state-of-the-art technology and methodologies to ensure comprehensive data collection and analysis. Gürkan's mission is to contribute to the development of safe and effective therapies that enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malatya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported